A saga dos Pain Killers

1. - Dez membros do painel de votantes do Food and Drug Administration (FDA), que autorizaram a continuação da venda dos "Pain Pills" têm ligações a laboratórios farmacêuticos - revela o "New York Times" (link)

O painel votou 31-1 a favor da manutenção do Celebrex (Pfizer) no mercado, 17-13 com duas abstenções decidiu a comercialização do Bextra (Pfizer) e 17-15 foram a favor de que o Vioxx (Merck) deveria voltar a ser vendido.

2. - If the 10 advisers had not cast their votes, the committee would have voted 12 to 8 that Bextra should be withdrawn and 14 to 8 that Vioxx should not return to the market. The 10 advisers with company ties voted 9 to 1 to keep Bextra on the market and 9 to 1 for Vioxx's return.
The votes of the 10 did not substantially influence the committee's decision on Celebrex because only one committee member voted that Celebrex should be withdrawn.